BackBrickell Biotech Overview

Brickell Biotech Long Term Debt

Brickell Biotech's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Brickell Biotech Long Term Debt History

Loading

Brickell Biotech vs. peers: Long Term Debt Comparison

Loading

Brickell Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brickell Biotech (BBI) FAQ

As of the most recent data (June 2022), BBI shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBI's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Brickell Biotech is outperforming or lagging.

Tracking BBI's long-term debt over time shows whether Brickell Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Brickell Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Brickell Biotech's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.